The role of CYP2C19*2 variant and other factors in clopidogrel resistance in Montenegrin ACS patients
Clopidogrel, an antiplatelet drug, has been widely prescribed for the treatment of acute coronary syndrome (ACS) for over two decades. Despite the fact that the drug proved to be effective in the majority of patients, in some, due to an inadequate response, the recurrence of adverse cardiovascular...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Sarajevo, Institute for Genetic Engineering and Biotechnology
2024-11-01
|
| Series: | Genetics & Applications |
| Subjects: | |
| Online Access: | https://genapp.ba/editions/index.php/journal/article/view/223 |